SLAMF7 and Miyoshi myopathy: Compared to PEL cell lines, the expression of SLAMF7/CD319 was weaker in MM cell lines and normal B cells from a healthy donor, while Z138 mantle lymphoma cells were found to be SLAMF7/CD319-negative.